Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Cited In for PubMed (Select 18997794)

1.

NF-κB-Mediated Regulation of Osteoclastogenesis.

Boyce BF, Xiu Y, Li J, Xing L, Yao Z.

Endocrinol Metab (Seoul). 2015 Mar 27;30(1):35-44. doi: 10.3803/EnM.2015.30.1.35. Review.

2.

NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways.

Rapino F, Abhari BA, Jung M, Fulda S.

Cell Death Dis. 2015 Mar 12;6:e1692. doi: 10.1038/cddis.2014.584.

3.

Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production.

Yu X, Deng Q, Li W, Xiao L, Luo X, Liu X, Yang L, Peng S, Ding Z, Feng T, Zhou J, Fan J, Bode AM, Dong Z, Liu J, Cao Y.

Oncotarget. 2015 Feb 10;6(4):1995-2008.

4.

Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages.

Jin J, Xiao Y, Hu H, Zou Q, Li Y, Gao Y, Ge W, Cheng X, Sun SC.

Nat Commun. 2015 Jan 7;6:5930. doi: 10.1038/ncomms6930.

PMID:
25565375
5.

The two faces of receptor interacting protein kinase-1.

Weinlich R, Green DR.

Mol Cell. 2014 Nov 20;56(4):469-80. doi: 10.1016/j.molcel.2014.11.001. Epub 2014 Nov 20. Review.

PMID:
25459879
6.
7.

Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.

Owens TW, Gilmore AP, Streuli CH, Foster FM.

J Carcinog Mutagen. 2013 May 27;Suppl 14. pii: S14-004.

8.

HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization.

Choi JS, Park BC, Chi SW, Bae KH, Kim S, Cho S, Son WC, Myung PK, Kim JH, Park SG.

Oncotarget. 2014 Oct 30;5(20):10084-99.

9.

Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1).

Lee S, Challa-Malladi M, Bratton SB, Wright CW.

J Biol Chem. 2014 Oct 31;289(44):30680-9. doi: 10.1074/jbc.M114.587808. Epub 2014 Sep 22.

PMID:
25246529
10.

Translational studies in older men using testosterone to treat sarcopenia.

Urban RJ, Dillon EL, Choudhary S, Zhao Y, Horstman AM, Tilton RG, Sheffield-Moore M.

Trans Am Clin Climatol Assoc. 2014;125:27-42; discussion 42-4.

11.

SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.

Rettinger E, Glatthaar A, Abhari BA, Oelsner S, Pfirrmann V, Huenecke S, Kuçi S, Kreyenberg H, Willasch AM, Klingebiel T, Fulda S, Bader P.

Front Pediatr. 2014 Jul 18;2:75. doi: 10.3389/fped.2014.00075. eCollection 2014.

12.

Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis.

Shen H, Sheng L, Chen Z, Jiang L, Su H, Yin L, Omary MB, Rui L.

Hepatology. 2014 Dec;60(6):2065-76. doi: 10.1002/hep.27348. Epub 2014 Oct 29.

PMID:
25088600
13.

Necroptotic signaling in adaptive and innate immunity.

Lu JV, Chen HC, Walsh CM.

Semin Cell Dev Biol. 2014 Nov;35:33-9. doi: 10.1016/j.semcdb.2014.07.003. Epub 2014 Jul 18.

PMID:
25042848
14.

TRAF3 regulates homeostasis of CD8+ central memory T cells.

Yi Z, Stunz LL, Lin WW, Bishop GA.

PLoS One. 2014 Jul 10;9(7):e102120. doi: 10.1371/journal.pone.0102120. eCollection 2014.

15.

Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.

Demchenko YN, Brents LA, Li Z, Bergsagel LP, McGee LR, Kuehl MW.

Oncotarget. 2014 Jun 30;5(12):4554-66.

16.

Regulation of NF-κB by TNF family cytokines.

Hayden MS, Ghosh S.

Semin Immunol. 2014 Jun;26(3):253-66. doi: 10.1016/j.smim.2014.05.004. Epub 2014 Jun 21. Review.

PMID:
24958609
17.

Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.

Gray CM, McCorkell KA, Chunduru SK, McKinlay MA, May MJ.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):341-6. doi: 10.1016/j.bbrc.2014.05.122. Epub 2014 Jun 2.

PMID:
24942881
18.

The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress.

Marivin A, Berthelet J, Plenchette S, Dubrez L.

Cells. 2012 Oct 10;1(4):711-37. doi: 10.3390/cells1040711.

19.

Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.

Michel M, Wilhelmi I, Schultz AS, Preussner M, Heyd F.

J Biol Chem. 2014 May 9;289(19):13651-60. doi: 10.1074/jbc.M113.526269. Epub 2014 Mar 26.

PMID:
24671418
20.

Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity.

Jin J, Hu H, Li HS, Yu J, Xiao Y, Brittain GC, Zou Q, Cheng X, Mallette FA, Watowich SS, Sun SC.

Immunity. 2014 Mar 20;40(3):342-54. doi: 10.1016/j.immuni.2014.02.006.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk